CR7162A - AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASES - Google Patents
AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASESInfo
- Publication number
- CR7162A CR7162A CR7162A CR7162A CR7162A CR 7162 A CR7162 A CR 7162A CR 7162 A CR7162 A CR 7162A CR 7162 A CR7162 A CR 7162A CR 7162 A CR7162 A CR 7162A
- Authority
- CR
- Costa Rica
- Prior art keywords
- treatment
- combination
- agent
- agonist
- polinergic
- Prior art date
Links
- 230000000414 obstructive effect Effects 0.000 title abstract 2
- 239000000556 agonist Substances 0.000 title 1
- 239000003795 chemical substances by application Substances 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 abstract 2
- 239000000812 cholinergic antagonist Substances 0.000 abstract 2
- 229940122086 Adenosine A2a receptor agonist Drugs 0.000 abstract 1
- 239000002465 adenosine A2a receptor agonist Substances 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 208000023504 respiratory system disease Diseases 0.000 abstract 1
- LERNTVKEWCAPOY-DZZGSBJMSA-N tiotropium Chemical class O([C@H]1C[C@@H]2[N+]([C@H](C1)[C@@H]1[C@H]2O1)(C)C)C(=O)C(O)(C=1SC=CC=1)C1=CC=CS1 LERNTVKEWCAPOY-DZZGSBJMSA-N 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
se refiere a una combinacion de un agonista selectivo del receptor A2a de adenosina y un agente anticolinergico para la administracion simultanea, consecutiva o separada por via de inhalacion en el tratamiento de una enfermedad obstructiva de las vias aereas u otra enfermedad inflamatoria, con la condicion de que el agente anticolinergico no sea una sal de tiotropio.refers to a combination of a selective adenosine A2a receptor agonist and an anticholinergic agent for simultaneous, consecutive or separate administration by inhalation in the treatment of an obstructive airway disease or other inflammatory disease, with the condition of that the anticholinergic agent is not a tiotropium salt.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29384201P | 2001-05-25 | 2001-05-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CR7162A true CR7162A (en) | 2004-02-23 |
Family
ID=34572599
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CR7162A CR7162A (en) | 2001-05-25 | 2003-11-19 | AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASES |
Country Status (4)
| Country | Link |
|---|---|
| CR (1) | CR7162A (en) |
| EC (1) | ECSP034863A (en) |
| PY (1) | PY0212140A (en) |
| ZA (1) | ZA200308465B (en) |
-
2002
- 2002-05-24 PY PY200200212140A patent/PY0212140A/en unknown
-
2003
- 2003-10-30 ZA ZA200308465A patent/ZA200308465B/en unknown
- 2003-11-19 CR CR7162A patent/CR7162A/en not_active Application Discontinuation
- 2003-11-25 EC ECSP034863 patent/ECSP034863A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PY0212140A (en) | 2004-07-01 |
| ZA200308465B (en) | 2004-11-01 |
| ECSP034863A (en) | 2004-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PA8546101A1 (en) | AN A2A ANTAGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS | |
| CR7152A (en) | A PDE4 INHIBITOR AND A COMBINATION ANTI-POLINERGIC AGENT TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROADS. | |
| BR0008039A (en) | Combinations of formoterol and a tiotropium salt | |
| BR0115910A (en) | Organic compounds | |
| MEP35308A (en) | COMPOUNDS SPECIFIC TO ADENOSINE A1, A2a, AND A3 RECEPTOR AND USES THEREOF | |
| NO2014028I2 (en) | Glucopyranosyl-substituted benzene derivatives, process for their preparation, physiologically acceptable salts of such compounds, drugs containing such compounds and combinations with other active substances, and their use in the manufacture of drugs for the treatment of disease | |
| NO2013017I1 (en) | (a) dextromethorphan or a pharmaceutically acceptable salt, precursor or derivative, for example, extromethorphan hydrobromide and especially dextromethorphan hydrobromide monohydrate; and (b) quinidine or a pharmaceutically acceptable salt, precursor or derivative thereof, for example quinidine and especially quinidine sulphate dihydrate | |
| UY27532A1 (en) | DOSAGE FORM OF DUAL CONTROLLED RELEASE. | |
| CY1106430T1 (en) | MEDICATIONS FOR INHALATION CONTAINING VITAMINS AND AN ANTICHOLINEPG | |
| BR0307320A (en) | Osmotic release system | |
| CR7162A (en) | AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLINERGIC AGENT FOR THE TREATMENT OF AIRWAY OBSTRUCTIVE DISEASES | |
| PY0228254A (en) | PHARMACEUTICAL COMBINATION | |
| UY27565A1 (en) | PHARMACEUTICAL COMBINATION | |
| AR044675A1 (en) | METHOD FOR THE TREATMENT OF SCHIZOPHRENIA IN A PATIENT WITH OVERWEIGHT | |
| BRPI0410374A (en) | pharmaceutical composition comprising valsartan | |
| UY27308A1 (en) | AN A2A AGONIST IN COMBINATION WITH AN ANTI-POLYNERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS | |
| HN2002000128A (en) | AN A2A AGONIST IN COMBINATION WITH AN ANTICHOLINERGIC AGENT FOR THE TREATMENT OF OBSTRUCTIVE DISEASES OF THE AIRWAYS. | |
| UY27564A1 (en) | PHARMACEUTICAL COMBINATION | |
| DOP2002000514A (en) | PHARMACEUTICAL COMBINATION | |
| BRPI0517983A (en) | corticosteroid use in combination with diuretic and antacid for treatment of vascular stenosis and prevention of vascular restenosis | |
| BR112021026291A2 (en) | Lemborexant to treat sleep problems | |
| ECSP034864A (en) | A PDE4 INHIBITOR AND AN ANTI-POLINERGIC AGENT IN COMBINATION TO TREAT OBSTRUCTIVE DISEASES OF RESPIRATORY ROADS | |
| CO5590922A2 (en) | USE OF ISTRADEFILINE (KW-6002) FOR THE TREATMENT OF CONDUCT DISORDERS | |
| AR077846A1 (en) | METHOD FOR DECREASING NASAL SYMPTOMS ASSOCIATED WITH NICOTINE ADMINISTRATION IN NASAL MUCOSA | |
| Stasia | Itraconazole/posaconazole |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal (granting procedure) |